- Venue Boston Marriott Peabody, MA
- Dates November 16-18, 2026
- Call +1-815-595-8049
Speakers
Kate-E-Broderick
PhD- Speciality: Chief Scientific and Innovation Officer
- Company: Artis Biosolutions
- Designation: Innovation Officer
Personal Information
Dr. Kate Broderick is the Chief Science and Innovation Officer at Artis Biosolutions and has more than 25 years of experience in the life science industry. A recognized nucleic acid vaccine expert, Dr. Broderick has a broad background in product development in the DNA therapeutic and RNA drug delivery field. Prior to joining Artis to lead their synthetic DNA efforts, Dr. Broderick was at Maravai Lifesciences as the Chief Innovation Officer and TriLink (part of the Maravai group) and the Senior Vice President of R&D.
Dr. Broderick was also the Senior Vice President of R&D at Inovio Pharmaceuticals overseeing their DNA-based developments. Dr. Broderick has served as a principal investigator for a variety of grants and awards from government agencies and non-profits, including the National Institutes of Health, CEPI and the Gates Foundation where she continues to act as an advisor. Dr. Broderick has authored over 100 peer reviewed publications and is the inventor on multiple patents in the nucleic acid space. She received her Ph.D from the University of Glasgow in Scotland and completed her post-doctoral research at the University of California, San Diego.
Scientia Meetings
Connecting Minds for Scientific Progress!
Join us in revolutionizing conferences! Scientia Meetings is launching events across the country, offering a unique platform for scientists and researchers to share knowledge, explore innovative ideas, and foster collaborations. Buy Ticket
Clients
Our Official
Our Official
Sponsors
Our curated gatherings ensure purposeful networking, creating opportunities tailored to your needs. Let's shape the future together—where knowledge connects, opportunities arise, and science thrives!
Buy Ticket
Get The Latest Updates
Signup For Newsletter
If You Want to Update For on Our Site a#Subscribe Now.